Skip to content
Search

Latest Stories

NHSE urged to end contracts with non-compliant DSPs amid rising pharmacy closures

There is clear evidence that the majority of distance selling pharmacies are operating in breach of their NHS contracts, and a failure to properly regulate 'pseudo' distance selling pharmacies is leading to local pharmacy closures, the Company Chemists' Association has reported.

According to the CCA’s recent findings, 72 per cent of DSPs dispense over 50 per cent of their prescriptions to patients within a single postcode area within 10 miles of the pharmacy.


"Operating within constrained geographical regions, pseudo-DSPs achieve reduced overheads and operational costs by focusing on localised marketing and medicine delivery. They compete against local brick-and-mortar pharmacies, causing them to lose vital trade," the CCA claimed, based on its recent survey – The Impact of Pseudo Distance Selling Pharmacies.

"As per their terms of service, DSPs are obligated to provide prescription delivery nationwide, extending beyond local patients," said the CCA, adding that the financial savings resulting from the lack of patient access are balanced by the necessity to function on a national scale.

Since 2015, there has been a net closure of 720 pharmacies, yet there has been a rise in the number of DSPs. While the CCA has provided evidence of malpractice to NHS England, no definitive actions have been taken to address these unfair trading practices, the CCA said.

Disparities in the framework 

NHS BSA data indicated that by the close of 2022, there were 374 'active' DSP contracts in England. The CCA examined prescriptions dispensed by each to identify the respective GP surgeries that prescribed them.

The CAA investigation revealed these disparities:

  • Out of the total, 268 (72 per cent) are failing to adhere to their NHS DSP contractual obligations, with over 50 per cent of their prescriptions originating from GPs in a sole postcode area within 10 miles of the pharmacy.
  • 28 (7 per cent) receive over 50 per cent of their prescriptions from GPs within a singular postcode area. However, over 50 per cent of their prescriptions originate from distances exceeding 10 miles from the pharmacy.
  • 15 (4 per cent) obtain up to 50 per cent of their prescriptions from GPs within a sole postcode area. Nonetheless, less than 50 per cent of their prescriptions originate from distances exceeding 10 miles from the pharmacy.
  • Merely 63 (16 per cent) receive prescriptions from all over the country and deliver the anticipated DSP service.

The CCA has urged NHSE to probe DSPs that appear to lack nationwide service provision, conduct audits for all DSPs, take action against those failing contractual duties, demand proof of nationwide service from DSPs, and revoke contracts of non-compliant DSPs.

"'Pseudo-DSPs' are causing potential barren areas, violating legal agreements, and accelerating pharmacy closures," said Malcolm Harrison, CEO of CCA. "Authentic DSPs provide essential medication access to numerous patients. Patient choice in accessing medicines and adjusting it as per their requirements holds significance. However, 'Pseudo-DSPs' disrupt the market. NHSE must annul contracts of DSPs that persistently fall short of contractual obligations."

"It is NHSE's responsibility to scrutinize, audit, and confront them, ensuring they cease to jeopardize direct access to pharmacy advice," he added.

‘NHSE neglecting self-regulation’

In response to the report, Nigel Swift, Managing Director of Rowlands, commented that the CCA report shows NHSE is not effectively enforcing its own regulations.

“DSPs find it simpler to gain operating permission compared to traditional pharmacies, as they are not required to exhibit a local pharmaceutical presence,” he said. “Although they are theoretically intended to serve the entire nation, NHSE seemingly doesn't verify this in practice. This neglects their duty and goes against government healthcare policy.”

“At a time when most pharmacies in England are facing severe financial pressures and we see hundreds of closures and mergers, unfair competition and a lack of a level playing field simply adds to the woes of the sector. Ultimately, it is patients who lose out if they cannot drop into their local pharmacy for professional healthcare advice and services.”

“If DSPs disregard the rules, NHSE must promptly take action,” Swift added.

Meanwhile, the NHSE Community Pharmacy Workforce Survey 2022 recently unveiled a 6 per cent decrease in the community pharmacy workforce. The survey data further highlighted a 16 per cent increase in pharmacist vacancy rates, signalling an elevated reliance on locum pharmacists who, on average, work fewer hours.

More For You

Pharmacy owners to receive 19p SAF increase in advance payments for April and May 2025

The Single Activity Fee (SAF) was increased by 19p to £1.46 per item, effective from April 2024.

gettyimages

19p SAF increase to be included in April and May 2025 advance payments

Following discussions with the Department of Health and Social Care (DHSC), Community Pharmacy England (CPE) has agreed a mechanism that will allow pharmacy owners to receive the 19p increase to the Single Activity Fee (SAF) earlier for the dispensing months of April and May 2025.

CPE said: “The advance payments for these dispensing months will be adjusted to incorporate the uplift to the SAF. No adjustment to advance payments will be required from the June 2025 dispensing month onwards.”

Keep ReadingShow less
CPE invites pharmacy owners to share their views on new CPCF funding settlement

What do you think should be the next priority for the Government?

gettyimages

Pharmacy owners asked to share their views on new CPCF arrangements

Community Pharmacy England (CPE) is urging pharmacy owners to share their views on the new Community Pharmacy Contractual Framework (CPCF) funding settlement ahead of its next full Committee meeting, scheduled for 30 April–1 May.

The Committee said it had agreed to the settlement "reluctantly," acknowledging that it represents a significant shift after years of real-terms funding cuts, while admitting that it’s “still not sufficient to match the continued scale of pressures facing pharmacy businesses.”

Keep ReadingShow less
Homecare medicines services face many challenges beyond pharmacy's control

Homecare medicines services face many challenges beyond pharmacy's control

gettyimages

GPhC calls for industry-wide collaboration to strengthen homecare medicines services

The General Pharmaceutical Council (GPhC) has called for industry-wide collaboration to improve homecare medicines services to ensure patients always receive their medicines when needed.

The call follows a recent review by the regulator, which identified several challenges facing homecare services, many of which were beyond the immediate control of the pharmacies providing them.

Keep ReadingShow less
Lack of funding deters NI pharmacy contractors from expanding portfolio

W G Hamilton Pharmacy is the third pharmacy in Northern Ireland to be recently sold to first-time buyers.

Pharmacy ownership trends shift in Northern Ireland due to funding gap

An increasing number of pharmacies in Northern Ireland are being acquired by first-time buyers, as existing contractors and groups pull back from expanding their portfolios amid ongoing funding pressures, according to specialist business property adviser Christie & Co.

Among the most recent sales is W G Hamilton Pharmacy, a busy community pharmacy in Ballysillan, North Belfast.

Keep ReadingShow less
RPS backs Pharmacist Support "Gift in Wills" initiative

The ‘Gift in Wills’ initiative is delivered in partnership with Bequeathed.

Photo credit: gettyimages

Leave a legacy: RPS partners with Pharmacist Support to promote ‘Gift in Wills’

The Royal Pharmaceutical Society (RPS) has announced its support for the ‘Gift in Wills’ initiative run by Pharmacist Support, coinciding with the charity’s birthday celebrations today (Tuesday 15 April).

This collaboration allows RPS members to create a free will while also helping to safeguard the future of vital support services for the pharmacy profession.

Keep ReadingShow less